Beijing Gene Key Life Technology Co., Ltd clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19
What changed in the last 30 days
1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-11-04 | NCT07915544 A Study of GKL-006Allo Injection in Patients With Ankylosing Spondylitis | Phase 1 | Not Yet Recruiting |
Active trials by phase
| Phase 1 | 3 | |
| Phase 1/2 | 2 | |
| Phase 2 | 1 |
Disease areas by active trials
Liver Cancer (2) · Ankylosing Spondylitis (1) · Pancreatic Cancer (1)
Get alerts when Beijing Gene Key Life Technology Co., Ltd's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.